MILabs, a Dutch developer of molecular imaging systems, has received the “Commercial Innovation of the Year” award at the recent World Molecular Imaging Congress (WMIC) in Seattle, WA. The award was presented for the company’s VECTor⁶ preclinical imaging system with its new broadband photon tomography technique.

The VECTor⁶ system advances state-of-the-art PET imaging by increasing PET resolution down to 0.55 mm for ¹⁸F and eliminating positron range effects for PET isotopes such as ¹²⁴I and ⁸²Rb. Moreover, the system can image multiple PET isotopes simultaneously and obtain both spatial and temporal co-registered PET/SPECT and PET/radiotherapy images, including those of all alpha- and beta-isotopes used in theranostics.

The VECTor⁶ also incorporates best-in-class in vivo optical and X-ray CT modalities, enabling nuclear and optical molecular imaging to be performed on a single platform. By imaging a photon energy range from 1 eV to 1 MeV, MILabs expects its broadband photon tomography technique will extend the applications of in vivo animal imaging far beyond the capabilities of current preclinical imaging systems.

“We are very encouraged that the molecular imaging community, including opinion leaders as well as industry peers, have recognized the technological innovations incorporated in our latest product, the VECTor6 system,” says Frederik Beekman, CEO/CSO of MILabs. “Especially for PET imaging, this product pushes the boundaries of performance beyond the limits of current preclinical systems.”